High Expectations During the Trump Administration

, New York Law Journal

   | 0 Comments

Brian Malkin, Chair of the Food, Drug and Cosmetic Law Section, and Bethany Hills, a Member of the Section Executive Committee, discuss numerous expectations for the FDA under the Trump Administration, and outline how the Section will prepare practitioners for changes.

This premium content is reserved for New York Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202777275123

Thank you!

This article's comments will be reviewed.